Laboratory Evaluation of FR10024, a New Cephalosporin Derivative

FR10024 is a broad-spectrum antibiotic. The in vitro antibacterial activity of FR10024 against clinical isolates of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis is greater than that of any of the cephalosporins developed to date. Indole-positive Proteus, Ente...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Nishida, Minoru, Murakawa, Takeo, Kamimura, Toshiaki, Okada, Naohiko, Fukada, Shigemi, Sakamoto, Hiroshi, Nakamoto, Shoji, Yokota, Yoshiko, Kono, Yoko
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1977
Assuntos:	Pharmacology and Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC351918/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/836014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.1.51
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!